Table 1.
Clinical, electrocardiographic and electrophysiological study characteristics
| Clinical presentations | N = 35 |
|---|---|
| Men | 25 (71.42%) |
| Age | 43.89 ± 13.1 years |
| Asymptomatic | 23 (65.7%) |
| Syncope | 5 (14.3%) |
| Palpitation | 6 (17.14%) |
| Electrocardiographic presentations | |
| Type I | 22 (62.85%) |
| Type II | 12 (34.30%) |
| Type III | 1 (2.85%) |
| Electrophysiological study | |
| Ventricular tachyarrhythmia | 16 (45.7%) |
| Refractory period | 228 ± 36 ms |
| HV interval | 49 ± 8.6 ms |
| Ajmaline / Procainamide | 11 (31.4%) |